Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

NCT00991029 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00991029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00991029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Lead sponsor
University of California, San Francisco
Phase
Phase 3
Overall status
Terminated
Start date
May 28, 2010
Completion date
April 9, 2018
Enrollment
4,881 (actual)
Sites
210

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic attack, transient